Navigating Insurance Challenges for High-Cost Cancer Treatments
Explore the complex insurance challenges surrounding high-cost cancer treatments like Keytruda and the legal battles patients face to access essential medications.
Explore the complex insurance challenges surrounding high-cost cancer treatments like Keytruda and the legal battles patients face to access essential medications.
Explore the launch of TrumpRx to lower prescription drug costs in the U.S. and its impact on healthcare affordability and reforms.
Discover how oral GLP-1 medications like Wegovy and Foundayo are transforming healthcare and improving accessibility to weight management solutions.
Minnesota's Senate approves a bill to support 340-B hospitals in acquiring discounted medications. Learn about its impact and legislative challenges ahead.
Explore proposed legislation aiming to cap insulin costs at $35, addressing financial burdens on families managing diabetes. Current healthcare challenges assessed.
Explore the MFN proposal to lower prescription drug costs while ensuring healthcare innovation and leadership in America.
Explore the challenges in insurance coverage for GLP-1 weight-loss medications as demand rises and insurers tighten restrictions.
Explore how Medicare Part B payment adjustments for self-administered medications impact beneficiaries and the healthcare market.
UCB's $2B investment in Atlanta and Florida's HIV medication expansion highlight key health industry trends. Explore the impacts and implications for healthcare.
Explore innovative pricing models for GLP-1 medications addressing accessibility issues created by insurance denials. Discover direct purchase options and Medicare initiatives.